Pharming B.V.

Location

Founded

Website

https://www.pharming.com

Risk Signals

427 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Stock Market Events (204) Financial Reporting (118) Earnings Reports & Warnings (83) Market Trends (73) Acquisition Announcements (70) Executive Leadership Changes (57) Investment Strategies (37) Corporate Insolvency (35) Political and Economic Developments (31) Shareholders Feedback (29) Equity Analysis & Ratings (28) Initial Public Offering Launch (17) Merger Announcements (16) Corporate Financial Crises (15) Asset Divestment (12) Competitive Market Dynamics (12) Regulatory Updates (12) Economic Policy Developments (11) Business Growth Initiatives (11) IT Infrastructure Disruption (10) Capital Funding Requests (9) Corporate Awards and Recognitions (9) Corporate Deals (9) Investor Activism (8) Revenue Generation Opportunities (8) New Product Release (7) Issuing Shares (7) Sustainable Practices (7) Inter-Organizational Collaborations (7) Corporate Governance Policies (7)

Recent Articles about Pharming B.V.

Live alerts from global media, monitored by Business Radar

Pharming expects EU to reject key drug, shares dive

2008-03-20 (reuters.com)

Pharming expects EU to reject key drug, shares dive

Dutch biotechnology firm Pharming Group NV expects the European Medicines Agency to deny approval for its key drug Rhucin, it said on Thursday, sending its shares sharply down.

Read more
Pharming expects EU to reject key drug, shares dive

2008-03-20 (reuters.com)

Pharming expects EU to reject key drug, shares dive

Dutch biotechnology firm Pharming Group NV expects the European Medicines Agency to deny approval for its key drug Rhucin, it said on Thursday, sending its shares sharply down.

Read more

Never miss a headline about Pharming B.V.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages